UBIAD1 and Schnyder corneal dystrophy: Currently, we are seeking drugs that accelerate the degradation of UBIAD1 related to SCD, trigger the transport of variants from ER to Golgi apparatus or prevent their interaction with reductase, which may prevent cholesterol accumulation and corneal opacity related to SCD.